480 related articles for article (PubMed ID: 17602150)
1. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
2. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.
García-López E; Anderstam B; Heimbürger O; Amici G; Werynski A; Lindholm B
Perit Dial Int; 2005; 25(2):181-91. PubMed ID: 15796147
[TBL] [Abstract][Full Text] [Related]
3. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality.
de Waart DR; Zweers MM; Struijk DG; Krediet RT
Perit Dial Int; 2001; 21(3):269-74. PubMed ID: 11475342
[TBL] [Abstract][Full Text] [Related]
4. Long Peritoneal Dialysis Dwells With Icodextrin: Kinetics of Transperitoneal Fluid and Polyglucose Transport.
Olszowska A; Waniewski J; Stachowska-Pietka J; Garcia-Lopez E; Lindholm B; Wańkowicz Z
Front Physiol; 2019; 10():1326. PubMed ID: 31736769
[No Abstract] [Full Text] [Related]
5. Predicting the Peritoneal Absorption of Icodextrin in Rats and Humans Including the Effect of α-Amylase Activity in Dialysate.
Akonur A; Holmes CJ; Leypoldt JK
Perit Dial Int; 2015; 35(3):288-96. PubMed ID: 24584610
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
7. Determination of alpha-amylase activity in serum and dialysate from patients using icodextrin-based peritoneal dialysis fluid.
Anderstam B; García-López E; Heimbürger O; Lindholm B
Perit Dial Int; 2003; 23(2):146-50. PubMed ID: 12713081
[TBL] [Abstract][Full Text] [Related]
8. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
Araújo Teixeira MR; Pecoits-Filho RF; Romão Junior JE; Sabbaga E; Marcondes MM; Abensur H
Perit Dial Int; 2002; 22(2):229-33. PubMed ID: 11990408
[TBL] [Abstract][Full Text] [Related]
9. Rate of synthetic oligosaccharide degradation as a novel measure of amylase activity in peritoneal dialysis patients.
García-López E; Werynski A; Heimbürger O; Filho JC; Lindholm B; Anderstam B
Perit Dial Int; 2008; 28(3):296-304. PubMed ID: 18474923
[TBL] [Abstract][Full Text] [Related]
10. Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis.
Stachowska-Pietka J; Waniewski J; Olszowska A; Garcia-Lopez E; Wankowicz Z; Lindholm B
Sci Rep; 2023 Apr; 13(1):6526. PubMed ID: 37085652
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
12. The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis.
Pawlaczyk K; Garcia-Lopez E; Kuzlan-Pawlaczyk M; Heimbürger O; Bergström J; Breborowicz A; Lindholm B
Perit Dial Int; 2001; 21 Suppl 3():S359-61. PubMed ID: 11887855
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Biocompatibility of Neutral Icodextrin Peritoneal Dialysis Fluid.
Shimada S; Mori T; Koizumi K; Sato S; Oba-Yabana I; Ohsaki Y; Sato E; Naganuma E; Kurasawa N; Tsuchikawa M; Ito S
Adv Perit Dial; 2016; 32():46-50. PubMed ID: 28988589
[TBL] [Abstract][Full Text] [Related]
15. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
16. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients.
Paniagua R; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Orihuela O; Prado-Uribe MD; Alcántara G; Amato D
Perit Dial Int; 2009; 29(4):422-32. PubMed ID: 19602608
[TBL] [Abstract][Full Text] [Related]
17. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
[TBL] [Abstract][Full Text] [Related]
19. The variability in ultrafiltration achieved with icodextrin, possibly explained.
Venturoli D; Jeloka TK; Ersoy FF; Rippe B; Oreopoulos DG
Perit Dial Int; 2009; 29(4):415-21. PubMed ID: 19602607
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years.
Posthuma N; Verbrugh HA; Donker AJ; van Dorp W; Dekker HA; Peers EM; Oe PL; ter Wee PM
Perit Dial Int; 2000; 20(2):174-80. PubMed ID: 10809240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
